HALO:NASDAQ
Halozyme Therapeutics, Inc.
63,96ย $
arrow_upward
+0,47%(+0,30) 1ะ
63,69ย $
arrow_downward
-0,42% (-0,27)bedtimeะะพัะปะต ะทะฐะบัััะธั ัะตััะธะธ
ะขะพัะณะธ ะทะฐะบัััั: 1 ะผะฐั, 16:00:01 GMT-4 · USD
search
ะัะต ัะธะผะฒะพะปั
1ะ
5ะะ
1ะะะก
6ะะะก
ะก1ะฏะ
1ะะะ
5ะะะข
ะะะะก
| ะกะธะผะฒะพะป | ะฆะตะฝะฐ | ะะทะผะตะฝะตะฝะธั | ะะธะฝะฐะผะธะบะฐ (%) |
|---|
insights_autoะกะพะทะดะฐะฝะธะต ััะฐัะธััะธะบะธ ะดะปั ัะธะบะตัะฐ HALOโฆ
ะัะบัััั
63,48ย $
ะััะพะบะฐั
64,31ย $
ะะธะทะบะฐั
62,38ย $
ะ ัะฝ. ะบะฐะฟ.
7,58ย ะผะปัะด
ะะฑัะตะผ
978,03ย ััั.
ะะพัััะธัะธะตะฝั P/E
25,01
ะะฐะบั. ัะตะฝะฐ ะทะฐ 52 ะฝะตะด.
82,22ย $
ะะธะฝ. ัะตะฝะฐ ะทะฐ 52 ะฝะตะด.
47,50ย $
ะัะธะฑัะปั ะฝะฐ ะฐะบัะธั
2,56ย $
ะะตัะฐ
1,03
ะะบัะธะธ ะฒ ะพะฑัะฐัะตะฝะธะธ
118,47ย ะผะปะฝ
ะงะธัะปะพ ัะพัััะดะฝะธะบะพะฒ
423
ะะพะฒะพััะธ
ะะท ะธััะพัะฝะธะบะพะฒ ะฒ ะธะฝัะตัะฝะตัะต
Stock Titan
·
1 ะดะตะฝั ะฝะฐะทะฐะด
Halozyme sets May 11 earnings release, call after market close
Yahoo Finance
·
1 ะดะตะฝั ะฝะฐะทะฐะด
Halozyme to Report First Quarter 2026 Financial and Operating Results
Minichart
·
1 ะดะตะฝั ะฝะฐะทะฐะด
Halozyme Therapeutics Appoints Darren Snellgrove as Chief Financial Officer in April 2026
Stock Titan
·
2 ะดะฝั ะฝะฐะทะฐะด
Johnson & Johnson finance veteran joins Halozyme as CFO on June 8
ะัะพัะธะปั
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
ะ ะบะพะผะฟะฐะฝะธะธ "Halozyme Therapeutics, Inc."
ะะตะฝะตัะฐะปัะฝัะน ะดะธัะตะบัะพัHelen I. Torley
ะะพะปะธัะตััะฒะพ ัะพัััะดะฝะธะบะพะฒ423
ะะฐัะฐ ะพัะฝะพะฒะฐะฝะธั1998
ะจัะฐะฑ-ะบะฒะฐััะธัะฐะกะฐะฝ-ะะธะตะณะพ, ะะฐะปะธัะพัะฝะธั, ะกะพะตะดะธะฝะตะฝะฝัะต ะจัะฐัั ะะผะตัะธะบะธ
ะกะตะบัะพั-
ะกะฐะนัhalozyme.com
ะกะพะทะดะฐะฝะฝัะน ะะ ะบะพะฝัะตะฝั ะผะพะถะตั ัะพะดะตัะถะฐัั ะพัะธะฑะบะธ. ะะพะดัะพะฑะฝะตะตโฆ
ะกะฟัะฐะฒะบะฐะัะฟัะฐะฒะธัั ะพัะทัะฒะะพะฝัะธะดะตะฝัะธะฐะปัะฝะพัััะฃัะปะพะฒะธัะัะบะฐะท ะพั ะพะฑัะทะฐัะตะปัััะฒ